BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36782083)

  • 1. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease.
    Chen W; Gullett JM; Tweedell RE; Kanneganti TD
    Eur J Immunol; 2023 Nov; 53(11):e2250235. PubMed ID: 36782083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes.
    Pandeya A; Kanneganti TD
    Trends Mol Med; 2024 Jan; 30(1):74-88. PubMed ID: 37977994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
    Sharma BR; Karki R; Rajesh Y; Kanneganti TD
    J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PANoptosis: Emerging mechanisms and disease implications.
    Qi Z; Zhu L; Wang K; Wang N
    Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
    Gullett JM; Tweedell RE; Kanneganti TD
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method.
    Wang Y; Pandian N; Han JH; Sundaram B; Lee S; Karki R; Guy CS; Kanneganti TD
    Cell Mol Life Sci; 2022 Sep; 79(10):531. PubMed ID: 36169732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis.
    Karki R; Kanneganti TD
    Curr Opin Immunol; 2023 Aug; 83():102348. PubMed ID: 37267644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis).
    Zheng M; Kanneganti TD
    Immunol Rev; 2020 Sep; 297(1):26-38. PubMed ID: 32729116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality.
    Pandian N; Kanneganti TD
    J Immunol; 2022 Nov; 209(9):1625-1633. PubMed ID: 36253067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence.
    Lee S; Karki R; Wang Y; Nguyen LN; Kalathur RC; Kanneganti TD
    Nature; 2021 Sep; 597(7876):415-419. PubMed ID: 34471287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Samir P; Malireddi RKS; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Christgen S; Zheng M; Kesavardhana S; Karki R; Malireddi RKS; Banoth B; Place DE; Briard B; Sharma BR; Tuladhar S; Samir P; Burton A; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():237. PubMed ID: 32547960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis).
    Banoth B; Tuladhar S; Karki R; Sharma BR; Briard B; Kesavardhana S; Burton A; Kanneganti TD
    J Biol Chem; 2020 Dec; 295(52):18276-18283. PubMed ID: 33109609
    [No Abstract]   [Full Text] [Related]  

  • 14. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.
    Wang Y; Kanneganti TD
    Comput Struct Biotechnol J; 2021; 19():4641-4657. PubMed ID: 34504660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of PANoptosis in cancer treatment.
    Xiong Y
    Biomed Pharmacother; 2023 Dec; 168():115696. PubMed ID: 37837884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANoptosis: Mechanisms, biology, and role in disease.
    Sun X; Yang Y; Meng X; Li J; Liu X; Liu H
    Immunol Rev; 2024 Jan; 321(1):246-262. PubMed ID: 37823450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programming inflammatory cell death for therapy.
    Christgen S; Tweedell RE; Kanneganti TD
    Pharmacol Ther; 2022 Apr; 232():108010. PubMed ID: 34619283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.
    Sundaram B; Pandian N; Mall R; Wang Y; Sarkar R; Kim HJ; Malireddi RKS; Karki R; Janke LJ; Vogel P; Kanneganti TD
    Cell; 2023 Jun; 186(13):2783-2801.e20. PubMed ID: 37267949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Caspase Activation to Assess Innate Immune Cell Death.
    Han JH; Tweedell RE; Kanneganti TD
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Understanding Activation and Function of the NLRC4 Inflammasome.
    Sundaram B; Kanneganti TD
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.